Hamer DH - Search Results

1

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.

Pincus SH, Song K, Maresh GA, Hamer DH, Dimitrov DS, Chen W, Zhang MY, Ghetie VF, Chan-Hui PY, Robinson JE, Vitetta ES. Pincus SH, et al. Among authors: hamer dh. J Virol. 2017 Jan 18;91(3):e01955-16. doi: 10.1128/JVI.01955-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27852851 Free PMC article.

2

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

Pincus SH, Song K, Maresh GA, Frank A, Worthylake D, Chung HK, Polacino P, Hamer DH, Coyne CP, Rosenblum MG, Marks JW, Chen G, Weiss D, Ghetie V, Vitetta ES, Robinson JE, Hu SL. Pincus SH, et al. Among authors: hamer dh. J Virol. 2017 Jan 18;91(3):e01360-16. doi: 10.1128/JVI.01360-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27795412 Free PMC article.

3

Rational design of drugs that induce human immunodeficiency virus replication.

Hamer DH, Bocklandt S, McHugh L, Chun TW, Blumberg PM, Sigano DM, Marquez VE. Hamer DH, et al. J Virol. 2003 Oct;77(19):10227-36. doi: 10.1128/jvi.77.19.10227-10236.2003. J Virol. 2003. PMID: 12970407 Free PMC article.

4

A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types.

Lueders KK, De Rosa SC, Valentin A, Pavlakis GN, Roederer M, Hamer DH. Lueders KK, et al. Among authors: hamer dh. AIDS Res Hum Retroviruses. 2004 Feb;20(2):145-50. doi: 10.1089/088922204773004851. AIDS Res Hum Retroviruses. 2004. PMID: 15018701

5

Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis.

McHugh L, Hu S, Lee BK, Santora K, Kennedy PE, Berger EA, Pastan I, Hamer DH. McHugh L, et al. Among authors: hamer dh. J Biol Chem. 2002 Sep 13;277(37):34383-90. doi: 10.1074/jbc.M205456200. Epub 2002 Jul 15. J Biol Chem. 2002. PMID: 12119300 Free article.

6

Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.

Bocklandt S, Blumberg PM, Hamer DH. Bocklandt S, et al. Among authors: hamer dh. Antiviral Res. 2003 Jul;59(2):89-98. doi: 10.1016/s0166-3542(03)00034-2. Antiviral Res. 2003. PMID: 12895692

7

Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it.

Hamer DH. Hamer DH. Curr HIV Res. 2004 Apr;2(2):99-111. doi: 10.2174/1570162043484915. Curr HIV Res. 2004. PMID: 15078175 Review.

8

Molecular characterization, reactivation, and depletion of latent HIV.

Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA. Brooks DG, et al. Among authors: hamer dh. Immunity. 2003 Sep;19(3):413-23. doi: 10.1016/s1074-7613(03)00236-x. Immunity. 2003. PMID: 14499116 Free article.

9

Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein.

Root MJ, Hamer DH. Root MJ, et al. Among authors: hamer dh. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5016-21. doi: 10.1073/pnas.0936926100. Epub 2003 Apr 17. Proc Natl Acad Sci U S A. 2003. PMID: 12702763 Free PMC article.

10

Enhancement of HIV infection by cellulose sulfate.

Tao W, Richards C, Hamer D. Tao W, et al. AIDS Res Hum Retroviruses. 2008 Jul;24(7):925-9. doi: 10.1089/aid.2008.0043. AIDS Res Hum Retroviruses. 2008. PMID: 18627218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters